Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eisai
CRO
Alzheimer's trials withheld brain injury risk disclosures: NYT
Between both companies, more than 560 people joined trials without being told they had a heightened risk of dangerous side effects, NYT reports.
Darren Incorvaia
Oct 24, 2024 11:33am
Eisai plants molecular glue SEED with $1.5B biobucks deal
Aug 6, 2024 10:24am
Eisai adopts Medidata's new clinical trial platform
Jul 25, 2024 3:05pm
BMS axes Eisai ADC pact 3 years after paying $650M
Jul 1, 2024 9:00am
Ensho emerges with phase 2-ready asset from Eisai unit
Jun 28, 2024 11:10am
FDA lays out donanemab concerns, Lilly vigorously defends safety
Jun 6, 2024 10:55am